Osaic Holdings
SBIO icon

Osaic Holdings’s ALPS Medical Breakthroughs ETF SBIO Stock Holding History

Osaic Holdings’s Portfolio SBIO Stock Details SBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$458K Sell
7,090
-1,849
-21% -$101K ﹤0.01% 3738
2026
Q1 		$468K Buy
8,939
+1,889
+27% +$96.1K ﹤0.01% 3420
2025
Q4 		$361K Buy
7,050
+6,462
+1,099% +$299K ﹤0.01% 3634
2025
Q3 		$20.9K Hold
588
– – ﹤0.01% 5900
2025
Q2 		$17.7K Sell
588
-147
-20% -$4.21K ﹤0.01% 5805
2025
Q1 		$21K Sell
735
-775
-51% -$24.5K ﹤0.01% 5336
2024
Q4 		$49.9K Sell
1,510
-223
-13% -$8.41K ﹤0.01% 4701
2024
Q3 		$64.7K Sell
1,733
-30
-2% -$1.09K ﹤0.01% 4555
2024
Q2 		$59.2K Sell
1,763
-915
-34% -$30.7K ﹤0.01% 4540
2024
Q1 		$95.7K Buy
2,678
+446
+20% +$15.4K ﹤0.01% 4284
2023
Q4 		$73.5K Sell
2,232
-415
-16% -$11.1K ﹤0.01% 4640
2023
Q3 		$72.1K Sell
2,647
-108
-4% -$3.25K ﹤0.01% 4746
2023
Q2 		$86.9K Sell
2,755
-447
-14% -$13.9K ﹤0.01% 4548
2023
Q1 		$87K Sell
3,202
-442
-12% -$13.3K ﹤0.01% 4557
2022
Q4 		$111K Sell
3,644
-1,872
-34% -$56.3K ﹤0.01% 4345
2022
Q3 		$166K Buy
5,516
+142
+3% +$4.49K ﹤0.01% 3924
2022
Q2 		$149K Sell
5,374
-2,470
-31% -$70.4K ﹤0.01% 4070
2022
Q1 		$265K Sell
7,844
-12,654
-62% -$439K ﹤0.01% 3781
2021
Q4 		$866K Sell
20,498
-2,352
-10% -$105K ﹤0.01% 2544
2021
Q3 		$1.04M Sell
22,850
-5,449
-19% -$250K ﹤0.01% 2311
2021
Q2 		$1.39M Sell
28,299
-15,632
-36% -$749K ﹤0.01% 2048
2021
Q1 		$2.21M Sell
43,931
-4,776
-10% -$264K 0.01% 1525
2020
Q4 		$2.5M Buy
48,707
+1,919
+4% +$91.3K 0.01% 1280
2020
Q3 		$1.93M Sell
46,788
-4,074
-8% -$168K 0.01% 1330
2020
Q2 		$2.13M Sell
50,862
-11,263
-18% -$444K 0.01% 1228
2020
Q1 		$1.31M Buy
+62,125
New +$2.38M 0.01% 1326

Other funds holding SBIO

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CIS
Connors Investor Services Wyomissing, Pennsylvania $1.16B AUM 27.24% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
MWM
Moran Wealth Management Naples, Florida $3.67B AUM 36.71% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Osaic Holdings's SBIO Position: Q2 2026 in Review

Osaic Holdings reduced its ALPS Medical Breakthroughs ETF (SBIO) stake by 21% in Q2 2026, selling an estimated $101K and leaving 7,090 shares worth $458K. The position accounts for ﹤0.01% of the portfolio, ranked #3738.

Osaic Holdings first reported a position in SBIO in Q1 2020 and has held it in 26 quarters since. The position peaked at $2.5M in Q4 2020. 66 funds tracked by Wall St. Rank hold SBIO as of Q2 2026.

  • Osaic Holdings held 7,090 shares of ALPS Medical Breakthroughs ETF worth $458K as of Q2 2026.
  • Osaic Holdings sold 1,849 ALPS Medical Breakthroughs ETF shares in Q2 2026, an estimated $101K.
  • ALPS Medical Breakthroughs ETF made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #3738 holding.
  • Osaic Holdings first reported a position in ALPS Medical Breakthroughs ETF in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's ALPS Medical Breakthroughs ETF position peaked at $2.5M in Q4 2020.
  • 66 funds tracked by Wall St. Rank held ALPS Medical Breakthroughs ETF as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.